136 related articles for article (PubMed ID: 12708818)
1. Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.
Heesen C; Bruegmann M; Gbdamosi J; Koch E; Mönch A; Buhmann C
Mult Scler; 2003 Mar; 9(2):213-4. PubMed ID: 12708818
[No Abstract] [Full Text] [Related]
2. Acute myelogenous leukemia following mitoxantrone treatment for multiple sclerosis.
Mogenet I; Simiand-Erdociain E; Canonge JM; Pris J
Ann Pharmacother; 2003 May; 37(5):747-8. PubMed ID: 12708958
[No Abstract] [Full Text] [Related]
3. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related leukemia in mitozantrone treated patients.
Goodkin DE
Mult Scler; 2003 Aug; 9(4):426. PubMed ID: 12926850
[No Abstract] [Full Text] [Related]
5. Therapy related acute myeloblastic leukaemia after mitoxantrone treatment in a patient with multiple sclerosis.
Delisse B; de Seze J; Mackowiak A; N'Kendjuo JB; Verier A; Derepeer O; Boisselier C; Devos P; Hautecoeur P; Vermersch P;
Mult Scler; 2004 Feb; 10(1):92. PubMed ID: 14760961
[No Abstract] [Full Text] [Related]
6. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
Ellis R; Boggild M
Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Jaster JH; Niell HB; Dohan FC; Smith TW
Neurology; 2003 Apr; 60(8):1399-400; author reply 1400. PubMed ID: 12707461
[No Abstract] [Full Text] [Related]
8. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis.
Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A
Neurol Sci; 2008 Jun; 29(3):185-7. PubMed ID: 18612769
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia induced by mitoxantrone in a multiple sclerosis patient.
Tanasescu R; Debouverie M; Pittion S; Anxionnat R; Vespignani H
J Neurol; 2004 Jun; 251(6):762-3. PubMed ID: 15311359
[No Abstract] [Full Text] [Related]
11. Leukaemia due to mitoxantrone.
Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
Stroet A; Gold R; Chan A
Neurology; 2012 Mar; 78(12):933; author reply 933-4. PubMed ID: 22431743
[No Abstract] [Full Text] [Related]
13. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Brassat D; Recher C; Waubant E; Le Page E; Rigal-Huguet F; Laurent G; Edan G; Clanet M
Neurology; 2002 Sep; 59(6):954-5. PubMed ID: 12297591
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone-associated acute myelogenous leukemia in a patient with high-risk adenocarcinoma of the prostate: a case report and brief review.
Bowles DW; Flaig TW
Cancer Invest; 2006; 24(5):517-20. PubMed ID: 16939961
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
Sumrall A; Dreiling B
J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
[TBL] [Abstract][Full Text] [Related]
16. Mitoxantrone-related acute leukemia in two MS patients.
Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
[TBL] [Abstract][Full Text] [Related]
17. Mitoxanthrone-induced acute myeloid leukaemia presenting with leukaemia cutis.
Fleming JD; Walsh S; Salisbury J; Du-Vivier AW; Mufti G
Eur J Dermatol; 2013; 23(3):419-20. PubMed ID: 23783563
[No Abstract] [Full Text] [Related]
18. A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.
Cattaneo C; Almici C; Borlenghi E; Motta M; Rossi G
Leukemia; 2003 May; 17(5):985-6. PubMed ID: 12750718
[No Abstract] [Full Text] [Related]
19. Therapy-related acute leukaemia with mitoxantrone: four years on, what is the risk and can it be limited?
Ellis R; Brown S; Boggild M
Mult Scler; 2015 Apr; 21(5):642-5. PubMed ID: 25013152
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
Martinelli V; Cocco E; Capra R; Salemi G; Gallo P; Capobianco M; Pesci I; Ghezzi A; Pozzilli C; Lugaresi A; Bellantonio P; Amato MP; Grimaldi LM; Trojano M; Mancardi GL; Bergamaschi R; Gasperini C; Rodegher M; Straffi L; Ponzio M; Comi G;
Neurology; 2011 Nov; 77(21):1887-95. PubMed ID: 22076543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
